MECHANISMS OF INDUCTION OF SKIN CANCER BY UV RADIATION

Holly Soehnge, Allal Ouhtit and Honnavara N. Ananthaswamy

Department of Immunology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd., Box 178, Houston, TX 77030

Received 10/20/97 Accepted 10/24/97

8. REFERENCES

1. H. M. Gloster & D. G. Brodland: The epidemiology of skin cancer. Dermatol Surg 22, 217-26 (1996)

2. S. Strom: Epidemiology of basal and squamous cell carcinomas of the skin. In: Basal and squamous cell skin cancers of the head and neck. Eds: Weber R., Miller M., Goepfert H., Williams and Wilkins, Baltimore 1-7 (1996)

3. S. Kanjilal & H. N. Ananthaswamy: Molecular biology of skin carcinomas. In: Basal and squamous cell skin cancers of the head and neck. Eds: Weber R., Miller M., Goepfert H., Williams and Wilkins, Baltimore 25-26 (1996)

4. A. Nataraj, J. C. Trent II & H. N. Ananthaswamy: p53 gene mutations and photocarcinogenesis. Photochem Photobiol 62. 218-30 (1995)

5. M. L. Kripke: Immunologic mechanisms in UV radiation carcinogenesis. Adv Cancer Res 34, 69-106 (1981)

6. S. Zigman, J. Fowler & A. L. Kraus. Black light induction of skin tumors in mice. J Invest Dermatol 67, 723-25 (1976)

7. P. T. Strickland: Photocarcinogenesis by near-ultraviolet (UVA) radiation in Sencar mice. J Invest Dermatol 87, 272-75 (1986)

8. R. B. Setlow, A. D. Woodhead & E. Grist: Animal model for ultraviolet radiation-induced melanoma: platyfish-swordtail hybrid. Proc Natl Acad Sci USA 86, 8922-26 (1989)

9. R. B. Setlow, E. Grist, K. Thompson & A. D. Woodhead: Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci USA 90, 6666-70 (1993)

10. S. Tornaletti & G. P. Pfeifer: UV damage and repair mechanisms in mammalian cells. BioEssays 18, 221-28 (1996)

11. D. L. Mitchell & R. S. Nairn: The biology of the (6-4) photoproduct. Photochem Photobiol 49, 805-19 (1989)

12. S. Tommasi, P. M. Swiderski, Y. Tu, B. E. Kaplan & G. P. Pfeifer: Inhibition of transcription factor binding by ultraviolet-induced pyrimidine dimers. Biochemistry 35, 15693-703 (1996)

13. B. A. Donahue, S. Yin, J. S. Taylor, D. Reines & P. C. Hanawalt: Transcript cleavage by RNA polymerase II arrested by a cyclobutane pyrimidine dimer in the DNA template. Proc Natl Acad Sci USA 91, 8502-6 (1994)

14. S. Gao, R. Drouin & G. P. Holmquist: DNA repair rates mapped along the human PGK1 gene at nucleotide resolution. Science 263, 1438-40 (1994)

15. Y. Tu, S. Tornaletti & G. P. Pfeifer: DNA repair domains within a human gene: selective repair of sequences near the transcription initiation site. EMBO J 15, 675-83 (1996)

16. I. Tessman: A mechanism of UV-reactivation. In: Abstracts of the bacteriophage meeting. Eds: Bukhari A., Ljungquist E., Cold Spring Harbor Laboratory, Cold Spring Harbor (1976)

17. F. Urbach, J. H. Epstein & P. D. Forbes: Ultraviolet carcinogenesis: experimental, global and genetic aspects. In: Sunlight and man. Ed: M Puthak, Tokyo University Press, Tokyo (1974)

18. M. Matsui & V. DeLeo: Photocarcinogenesis by Ultraviolet A and B. In: Skin cancer: mechanisms and human relevance. Ed: H. Mukhtar, CRC Press, Boca Raton (1995)

19. I. Willis, J. M. Menter & H. J. White: The rapid induction of cancers in the hairless mouse utilizing the principle of photoaugmentation. J Invest Dermatol 76, 404-10 (1981)

20. B. Staberg, H. C. Wulf, H. C. Poulsen, P. Klemp & H. Brodthagen: The carcinogenic effect of UVA irradiation. J Invest Dermatol 81, 517-20 (1983)

21. A. de Laat, E. D. Kroon & F. R. de Gruijl: Cell cycle effects and concomitant p53 expression in hairless murine skin after longwave UVA (365 nm) irradiation: a comparison with UVB irradiation. Photochem Photobiol 65, 730-35 (1997)

22. T. Herzinger, J. O. Funk, K. Hillmer, D. Eick, D. A. Wolf & P. Kind: Ultraviolet B irradiation-induced G2 cell cycle arrest in human keratinocytes by inhibitory phosphorylation of the cdc2 cell cycle kinase. Oncogene 11, 2151-56 (1995)

23. Z.-G. Liu, R. Baskaran, E. T. Lea-Chou, L. D. Wood, Y. Chen, M. Karin & J. Y. J. Wang: Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature 384, 273-76 (1996)

24. Q. Zhan, F. Carrier & A. J. Fornace Jr: Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol Cell Biol 13, 4242-8 (1993)

25. F. Ponten, B. Berne, Z. Ren, M. Nister & J. Ponten: Ultraviolet light induces expression of p53 and p21 in human skin: effect of sunscreen and constitutive p21 expression in skin appendages. J Invest Dermatol 105, 402-406 (1995)

26. D. M. Milne, L. E. Campbell, D. G. Campbell & D. W. Meek: p53 is phosphorylated in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-Jun kinase, JNK1. J Biol Chem 270, 5511-18 (1995)

27. X. Q. Wang, B. G. Gabrielli, A. M. Milligan, J. L. Dickinson, T. M. Antalis & K. A. O. Ellem: Accumulation of p16^CDKN2A in response to ultraviolet irradiation correlates with a late S-G₂-phase cell cycle delay. Cancer Res 56, 2510-14 (1996)

28. J. Cotton & D. F. Spandau: Ultraviolet B-radiation dose influences the induction of apoptosis and p53 in human keratinocytes. Radiation Res 147, 148-55 (1997)

29. J. E. Cleaver & K. H. Kraemer: Xeroderma pigmentosum. In The Metabolic Basis of Inherited Disease, Vol. II (Scriver CR, Beaudet AL, Sly WS, Valle D, eds). New York: McGraw-Hill, 2949-71 (1989)

30. V. Dhar, V. Adler, A. Lehmann & Z. Ronai: Impaired Jun-NH2-terminal kinase activation by ultraviolet irradiation in fibroblasts of patients with Cockayne Syndrome complementation group B. Cell Growth & Differentiation 7, 841-46 (1996)

31. S. Kanjilal & H. N. Ananthaswamy: The role of oncogenes and tumor suppressor genes in ultraviolet-induced skin cancer. In: Skin cancer: mechanisms and human relevance. Ed: Mukhtar H, CRC Press, Boca Raton (1995)

32. B. Bienz, R. zakut-houri, D. Givol & M. Oren: Analysis of the gene coding for the murine cellular tumor antigen p53. EMBO J 3, 2179-83 (1984)

33. C. C. Harris: Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. JNCI 88, 1442-55 (1996)

34. M. B. Kastan, A. I. Radin, S. J. Kuerbitz, O. Onyekwere, C. A. Wolcow, C. I. Civin, K. D. Stone, T. Woo, Y. Ravindranath & R. W. Craig: Levels of p53 protein increase with maturation in human hematopoietic cells. Cancer Res 51, 4279-86 (1991)

35. L. C. Huang, K. C. Clarkin & G. M. Wahl: Sensitivity and selectivity of the DNA damage sensor responsible for activiting p-

53 dependent G1 arrest. Proc Natl Acad Sci USA 93, 4827-32 (1996)

36. A. Di Leonardo, S. P. Linke, K. Clarkin & G. M. Wahl. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev 8, 2540-51 (1994)

37. W. S. El-Deiry, T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler & B. Vogelstein: WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-25 (1993)

38. J. W. Harper, G. R. Adami, N. Wei, K. Keyomarsi & S. J. Elledge: The p21 Cdk interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-16 (1993)

39. T. Russo, N. Zambrano, F. Esposito, R. Ammendola, F. Cimino, M. Fiscella, J. Jackman, P.M. O'connor, C. W. Anderson & E. Appella: A p53-independent pathway for activation of WAF/CIP1 expression following oxidative stress. J Biol Chem 270, 29386-91 (1995)

40. A. Dutta, J. M. Ruppert, J. C. Aster & E. Winchester: Inhibition of DNA replication factor RPA by p53. Nature 365, 79-82 (1993)

41. X. W. Wang, H. Yeh, L. Schaeffer, R. Roy, V. Moncollin, J. M. Egly & : p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat Genet 10, 188-95 (1995)

42. C. Gobert, L. Bracco, F. Rossi, M. Olivier, J. Tazi, F. Lavell & : Modulation of DNA topoisomerase activity by p53. Biochemistry 35, 5578-86 (1996)

43. Y. Cho, S. Gorina, P. D. Jeffrey, N. P. Pavletich, Crystal structure of p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265, 346-55 (1994)

44. S. Rowan, R. L. Ludwig, Y. Haupt, S. Bates, X. Lux, M. Oren & : Specific loss of apoptotic but not cell cycle arrest function in human tumour derived p53 mutant. EMBO J 15, 827-38 (1996)

45. L. A. Donehower, M. Harvey, B. L. Slagle, M. J. McArthur, C. A. Montgomery, J. S. Butel & A. Bradley: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-21 (1992)

46. E. Shaulian, Y. Haviv, M. Oren: Transcriptional repression by C-terminal domain of p53. Oncogene 10, 671-80 (1995)

47. M. Harvey, H. Vogel, D. Morris, A. Bradley, A. Bernstein & L. A. Donehower: A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice. Nature Genet 9,305-11 (1995)

48. R. K. Brachmann, M. Vidal & J. D. Boeke: Dominant-negative p53 mutations selected in yeast hit cancer hot spots. Proc Natl Acad Sci. USA 93, 4091-5 (1996)

49. M. Hsiao, J. Low, E. Dorn, D. Ku, P. Pattengale, J. Yeargin & : Gain of function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness. Am J Pathol 145, 402-14 (1994)

50. M. Hollstein, B. Shomer, M. Greenblatt, T. Soussi, E. Hovig, R. Montesano & C. C. Harris: Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucl Aci Res 24, 141-6 (1996)

51. F. Ponten, C. Berg, A. Ahmadian, Z-P. Ren, M. Nister, J. Lundeberg, M. Uhlen & J. Ponten: Molecular pathology in basal cell cancer with p53 as a genetic marker. Onccgene 15, 1059-67 (1997)

52. M. S. Greenblatt, W. P. Bennett, M. C. Hollstein & C. C. Harris: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54, 4855-78 (1994)

53. D. E. Brash, J. A. Rudolph, J. A. Simon, A. Lin, G. J. McKenna, H. P. Baden, A. J. Halperin & J. Ponten: A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci. USA 88, 10124-8 (1991)

54. A. Ziegler, D. J. Leffell, S. Kunala, H. W. Sharma, M. Gailani, J. A. Simon, A. J. Halperin, H. P. Baden, P. E. Shapiro, A. E. Bale & D. E. Brash: Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancer. Proc Natl Acad Sci. USA 90, 4216-20 (1993)

55. P. Rady, F. Scinicariello, R. F. Wagner & S. K. Tyring: p53 mutations in basal cell carcinomas. Cancer Res. 52, 3804-06 (1992)

56. S. Kanjilal, W. E. Pierceall, K. K. Cummings, M. L. Kripke & H. N. Ananthaswamy: High frequency of p53 mutations in ultraviolet radiation-induced murine skin tumors: evidence for strand bias and tumor heterogeneity. Cancer Res 53, 2961-64 (1993)

57. H.N. Ananthaswamy, S. M. Loughlin, P. Cox, R. L. Evans, S. E. Ullrich & M. L. Kripke: Sunlight and skin cancer: inhibition of p53 mutations in UV-irradiated mouse skin by sunscreens. Nature Med 3, 510-14 (1997)

58. S. Kress, C. Sutter, P. T. Strickland, H. Mukhtar, J. Schweitzer & M. Schwarz: Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin. Cancer Res 52, 6400-3 (1992)

59. A. S. Jonason, S. Kunala, G. J. Price, R. J. Restifo, H. M. Spinelli, J. A. Persing,D. J. Leffell, R. E. Tarone & D. E. Brash: Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci. USA 93, 14025-9 (1996)

60. A. Ziegler, A. S. Jonason, D. J. Leffell, J. A. Simon, H. W. Sharma, J. Kimmelman, L. Remington, T. Jacks & D. E. Brash: Sunburn and p53 in the onset of skin cancer. Nature 372, 773-6 (1994)

61. M. A. Nelson, J. G. Einspahr, D. S. Alberts, C. A. Balfour, J. A. Wymer, K. L. Welch, S. J. Salasche, J. L. Bangert, T. M. Grogan & P. O. Bozzo: Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. Cancer Lett 85, 23-9 (1994)

62. N. Dumaz, C. Drougard, A. Sarasin & L. Daya-Grosjean: Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients. Proc Natl Acad Sci USA 90, 10529-33 (1993)

63. M. Sato, C. Nishigori, M. Zghal, T. Yagi & H. Takebe: Ultraviolet-specific mutations in the p53 gene in skin tumors in xeroderma pigmentosum patients. Cancer Res . 53, 2944-46 (1993)

64. F. Hutchinson: Induction of tandem-base change mutations. Mut Res 309, 11-5 (1994)

65. P. C. Hanawalt: Preferential repair of damage in actively transcribed DNA sequences in vivo. Genome 31, 605-11 (1989)

66. I. Mellon V. A. Bohr, C. A. Smith & P.C. Hanawalt: Preferential DNA repair of an active gene in human cells. Proc Natl Acad Sci USA 83, 8878-82 (1986)

67. E. R. Fearon & B. Vogelstein: A genetic model for colorectal tumorogenesis. Cell 61, 759-67 (1990)

68. C. Campbell, A. G. Quinn, Y.-S. Ro, B. Angus & J. L. Rees: p53 mutations are common and early events that preceds tumor invasion in squamous cell neoplasia of the skin. J Invest Dermatol 100, 746-8 (1993)

69. H. Nakazawa, D. English, P. L. Randell, K. Nakazawa, K. Martel, B. K. Armstrong & H. Yamasaki: UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. Proc Natl Acad Sci USA 91:360-364, 1994

70. A. Ouhtit, M. Ueda, H. Nakazawa, M. Ichihashi, N. Dumaz, A. Sarasin & H Yamasaki: Quantitative detection of UV-specific p53 mutations in normal skin from Japanese patients. Cancer Epid, Biom Prev 6, 433-38 (1997)

71. A. Ouhtit, H. Nakazawa, B. K. Armstrong, A. Kricker, E. Tan, Hiroshi Yamasaki & D. R. English: UV-specific p53 mutation frequency in normal skin as potential predictor of non-melanocytic skin cancer risk: case-control study in australia. J Natl Cancer Inst (In press)

72. J. W. Berg, H. J. van Kranen, H. G. Rebel, A. de Vries, W. A. van Vloten, C. F. van Kreul & F. R. de Gruul: Early p53 alterations in mouse skin carcinogenesis by UVB radiation: immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells. Proc Natl Acad Sci. USA 93, 274-8 (1996)

73. Z.-P. Ren, A. Hedrum, F. Ponten, M. Nister, A. Ahmadian, J. Lundeberg, M. Uhlen & J. Ponten: Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes. Oncogene 12, 765-73 (1996)

74. Z.-P. Ren, F. Ponten, M. Nister & J. Ponten: Two distinct p53 immunohistochemical patterns in human sqamous-cell skin cancer, precursors and normal epidermis. Int J Cancer (Pred Oncol) 69, 174-9 (1996)

75. Z-P. Ren, A. Ahmadian, F. Ponten, M. Nister, C. Berg, J. Lundeberg, M. Uhlen & J. Ponten: Benign clonal keratinocyte patches with p53 mutations show no genetic link to synchronous squamous cell precancer or cancer in human skin. Am J Path 150, 1791-803 (1997)

76. D. J. Leffell & D. E. Brash: Sunlight and skin cancer. Sci Am 38-43 (1996)

77. J. E. Hooper & M. P. Scott: The Drosophila patched gene encodes a putative membrane protein required for segmental patterning. Cell 59, 751-65 (1989)

78. Y. Nakano, I. Guerrero, A. Hidalgo, A Taylor, J. R. S. Whittle & P. W. Ingham: A protein with several possible membrane-spanning domains encoded by the Drosophila segment polarity gene patched. Nature 341, 508-13 (1989)

79. J. Alcedo, M. Ayzenzon, T. Von Ohlen, M. Noll & J. E. Hooper: The Drosophila smoothened gene encodes a seven-pass membrane protein, a putative receptor for the Hedgehog signal. Cell 86, 221-32 (1996)

80. J. Hepker, Q. Wang, C. K. Motzny, R. Holmgren & T. V. Orenic: Drosophila cubitus interruptis forms a negative feedback loop with patched and regulated expression of Hedgehog target genes. Development 124, 549-58 (1997)

81. L. V. Goodrich, R. L. Johnson, L. Milenkovic, J. A. McMahon & M. P. Scott: Conservation of the hedgehog/patched signaling pathway from flies to mice: induction of a mouse patched gene by Hedgehog. Genes & Dev 10, 301-12 (1996)

82. H. Hahn, C. Wicking, P. G. Zaphiropoulos, M. R. Gailani, S. Shanley, A. Chidambaram, I. Vorechovsky, E. Holmberg, A. B. Unden, S. Gillies, K. Negus, I. Smyth, C. Pressman, D. J. Leffell, B. Gerrard, A. M. Goldstein, M. Dean, R. Toftgard, G. Chenivix-Trench, B. Wainwright & A. E. Bale: Mutations of the human homolog of Drosophila patched in the Nevoid Basal Cell Carcinoma Syndrome. Cell 85, 841-51 (1996)

83. R. L. Johnson, A. L. Rothman, J. Xie, L. V. Goodrich, J. W. Bare, J. M. Bonifas, A. G. Quinn, R. M. Myers, D. R. Cox, E. H. Epstein Jr. & M. P. Scott: Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272, 1668-70 (1996)

84. V. Marigo, D. J. Roberts, S. M. Lee, O. Tsukurov, T. Levi, J. M. Gastier, D. J. Epstein, D. J. Gilbert, N. G. Copeland, C. E. Seidman: Cloning, expression, and chromosomal location of SHH and IHH: two human homologues of the Drosophila segment polarity gene hedgehog. Genomics 28, 44-51 (1995).

85. D. M. Stone, M. Hynes, M. Armanini, T. A. Swanson, Q. Gu, R. L. Johnson, M. P. Scott, D. Pennica, A. Goddard, H. Phillips, M. Noll, J. E. Hooper, F. de Sauvage & A. Rosenthal: The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog. Nature 384, 129-34 (1996)

86. A. B. Unden, E. Holmberg, B. Lundh-Rozell, M. Stahle-Backdahl, P. G. Zaphiropoulos, R. Toftgard & I. Vorechovsky: Mutations in the human homologue of Drosophila patched (PTCH) in basal cell carcinomas and the Gorlin Syndrome: different in vivo mechanisms of PTCH inactivation. Cancer Res 56, 4562-65 (1996)

87. A.E. Bale: Variable expressivity of patched mutations in flies and humans. Am J Hum Genet 60, 10-12 (1997)

88. A. B. Unden, P. G. Zaphiropoulos, K. Bruce, R. Toftgard & M. Stahle-Backdahl: Human patched (Ptch) mRNA is overexpressed consistently in tumor cells of both familial and sporadic basal cell carcinoma. Cancer Res 57, 2336-40 (1997)

89. A. E. Oro, K. M. Higgins, Z. Hu, J. M. Bonifas, E. H. Epstein Jr. & M. P. Scott: Basal cell carcinomas in mice overexpressing sonic hedgehog. Science 276, 817-21 (1997)

90. H. Fan, A. E. Oro & M. P. Scott: Induction of basal cell carcinoma features in transgenic human skin expressing Sonic Hedgehog. Nature Med 3, 788-92 (1997)

91. A. M. Goldstein, B. Pastakia, J. J. DiGiovanna, S. Poliak, S. Santucci, R. Kase, A. E. Bale & S. J. Bale: Clinical finding in two African-American families with the Nevoid Basal Cell Carcinoma Syndrome (NBCC). Am J Med Genet 50, 272-81 (1994)

92. C. Wicking, S. Shanley, I. Smyth, S. Gillies, K. Negus, S. Graham, G. Suthers, N. Haites, M. Edwards, B. Wainwright & G. Chenevix-Trench: Most germ-line mutations in the Nevoid Basal Cell Carcinoma Syndrome lead to a premature termination of the Patched protein, and no genotype-phenotype correlations are evident. Am J Hum Genet 60, 21-6 (1997)

93. L. A. Applegate, L. H. Goldberg, R. D. Ley & H. N. Ananthaswamy: Hypersensitivity of skin fibroblasts from Basal Cell Nevus Syndrome patients to killing by ultraviolet B but not by ultraviolet C radiation. Cancer Res 50, 637-41 (1990)

94. M. R. Gailani, M. Stahle-Backdahl, D. J. Leffell, M. Glynn, P. G. Zaphiropoulos, C. Pressman, A. B. Unden, M. Dean, D. E. Brash, A. E. Bale & R. Toftgard: The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nature Genet 14, 78-81 (1996)

95. M. Wolter, J. Reifenberger, C. Sommer, T. Ruzicka & G. Reifenberger: Mutations in the human homologue of the Drosophila segment polarity gene patched (Ptch) in sporadic basall cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 57, 2581-85 (1997)

96. M. Barbacid: Ras genes. Annu Rev Biochem 56, 779-95 (1987)

97. J. Marx: Forging a path to the nucleus. Science 360, 1588-61 (1993)

98. F. McCormick: Signal transduction. How receptors turn ras on. Nature 363, 15-21 (1993)

99. J. L. Bos: Ras oncogenes in human cancer: a review. Cancer Res 49, 4682-94 (1989)

100. U. S. Vogel: Cloning of bovine GAP and its interaction with oncogenic ras p21. Nature 335, 90-6 (1988)

101. H. N. Ananthaswamy & W. E. Pierceall: Molecular mechanisms of ultraviolet radiation carcinogenesis. Photochem Photobiol 1 52, 1119-36 (1990)

102. L. Daya-Grosjean, C. Robert, C. Drougard, J. Suarez & A. Sarasin: High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma-pigmentosum patients. Cancer Res 53, 1625-29 (1993)

103. K. Ishizaki, T. Tsujimura, M. Nakai, C. Nishigori, K. Sato, S. Katayama, O. Kurimura, K. Yoshikawa, S. Immamura, & M. Ikenaga: Infrequent mutations in the ras genes in skin tumors of xeroderma pigmentosum patients in Japan. Int J cancer 50, 382-5 (1992)

104. M. Sato, C. Nishigori, Y. Lu, M. Zghal & T. Yagi: Far less frequent mutations in ras genes than in the p53 gene in skin tumors of xeroderma pigmentosum patients. Mol Carcinog 11, 98-105 (1994)

105. W. E. Pierceall, L. H. Goldberg, M. A. Tainsky, T. Mukhopadhyay & H. N. Ananthaswamy: Ras gene mutation and amplification in human nonmelanoma skin cancers'. Mol. Carcinogen 4, 196-202 (1991)

106. R. Dover & N. A. Wrigth. In: Dermatology in general medicine. EdsT. B. Fitzpatrick, A, Z. Eisen, K. Wolff, I. M. Freedberg & K. F. Austen, McGraw-Hill, NY (1993)

107. K. H. Kraemer: Sunlight and skin cancer: another link revealed. Proc Natl Acad Sci. USA 94, 11-4 (1997)

108. A. Liebermann, B. Hoffman & R. A. Steinman: Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene 11, 199-210 (1995)

109. N. S. Pellegata, R. J. Antoniono, J. L. Redpath & E. J. Stanbridge: DNA damage and p53-mediated cell cycle arrest: a reevaluation. Proc Natl Acad Sci. USA 93, 15209-14 (1996)

110. P. Golstein: Controlling cell death. Science 275, 1081-2 (1997)

111. K. Goi, M. Takagi, S. Iwata, D. Delia, M. Asada, R. Donghi, Y. Tsunematsu, S. Nakasawa, H. Yamamoto, J. Yokota, K. Tamura, Y. Saeki, J. Utsunomiya, T. Takahashi, R. Ueda, C. Ishioka, M. Eguchi, N. Kamata& s. Mizutani: DNA damage-associated dysregulation of the cell cycle and apoptosis control in cells with germ-line p53 mutation. Cancer Res 57, 1895-902 (1997)

112. S. Tornaletti & G. P. Pfeifer: Slow repair of pyrimidine dimers at p53 mutation hotspots in skin cancer. Science 263, 1436-8 (1994)

113. K. W. Kinzler & B. Vogelstein: Gatekeepers and caretakers. Nature 386, 761-3 (1997)

114. A. J. Levine: p53, the cellular gatekeeper for growth and division. Cell 88, 323-31 (1997)

115. D. R. Goudie, M. A. Ywille, M. A. Leversha, R. A. Furlong, N. P. Carter, M. J. Lush, N. A. Affara & M. A. Ferguson-Smith: Multiple self-healing squamous epithelioma (ESS1) mapped to chromosome 9q22-q31 in families with common ancestry. Nat Genet 3, 165-9 (1993)

116. S. E. Ullrich: The role of epidermal cytokines in the generation of cutaneous immune reactions and ultraviolet radiation-induced immune suppression. Photochem Photobiol. 62, 389-401 (1995)

117. E. C. DeFabo & F. P. Noonan: Mechanism of immune suppression by ultraviolet irradiation in vivo: I. Evidence for the existence of a unique photoreceptor in skin and its role in photoimmunology. J Exp Med 158, 84-92 (1983)

118. J. Boyle, R. M. MacKie, J. D. Briggs, B. J. R. Junor & T. C. Aitchison: Cancer, warts, and sunshine in renal transplant patients: a case-controlled study. Lancet 702-05 (1984)

119. M. T. Glover, C. M. Proby & I. M. Leigh: Skin cancer in renal transplant patients. Cancer Bull 45, 220-22 (1993)

120. A. A. Vink, D. B. Yarosh & M. L. Kripke: Chromophore for UV-induced immunosuppression: DNA. Photochem Photobiol 63, 383-86 (1996)